Telomerase regulation: A key to inhibition? (Review)

Gómez,Diego  L. Mengual; Farina,Hernán   G.; Gómez,Daniel  E.

doi:10.3892/ijo.2013.2104

Telomerase regulation: A key to inhibition? (Review)

Authors:
- Diego L. Mengual Gómez
- Hernán G. Farina
- Daniel E. Gómez
View Affiliations

Affiliations: Laboratory of Molecular Oncology, Science and Technology Department, National University of Quilmes, Buenos Aires, Argentina
Published online on: September 16, 2013 https://doi.org/10.3892/ijo.2013.2104
Pages: 1351-1356

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Telomerase has been recognized as a common factor in most tumor cells, and in turn a distinctive feature with respect to non-malignant cells. This feature has made telomerase a promising target for cancer therapy. Telomerase studies revealed that it is a multi-subunit complex possessing different levels of regulation, including control of expression, phosphorylation state, assembly and transportation to sites of activity. Thus, we emphasize that targeting telomerase expression or activity is not the only way to shorten telomeres, induce cell senescence and apoptosis. Therefore, there are multiple sites capable of allowing the modulation of its enzymatic activity. In the development of strategies based on the regulation of telomerase activity the understanding of the mechanisms regulating their subunits is essential. Based on this, in this review we summarize the current state of knowledge of some regulatory mechanisms of the components of the telomerase complex, and hypothetize their potential therapeutic application against cancer.

View Figures

View References

1.	Blackburn EH: Structure and function of telomeres. Nature. 350:569–573. 1991. View Article : Google Scholar : PubMed/NCBI
2.	Moyzis RK, Buckingham JM, Cram LS, et al: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA. 85:6622–6626. 1988. View Article : Google Scholar : PubMed/NCBI
3.	Griffith JD, Comeau L, Rosenfield S, et al: Mammalian telomeres end in a large duplex loop. Cell. 97:503–514. 1999. View Article : Google Scholar : PubMed/NCBI
4.	Greider CW: Telomeres do D-loop-T-loop. Cell. 97:419–422. 1999. View Article : Google Scholar : PubMed/NCBI
5.	De Lange T: Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19:2100–2110. 2005.PubMed/NCBI
6.	Neidle S: Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer. FEBS J. 277:1118–1125. 2010. View Article : Google Scholar : PubMed/NCBI
7.	O’Sullivan RJ and Karlseder J: Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol. 11:171–181. 2010.PubMed/NCBI
8.	Palm W and de Lange T: How shelterin protects mammalian telomeres. Annu Rev Genet. 42:301–334. 2008. View Article : Google Scholar : PubMed/NCBI
9.	Smogorzewska A and de Lange T: Regulation of telomerase by telomeric proteins. Annu Rev Biochem. 73:177–208. 2004. View Article : Google Scholar : PubMed/NCBI
10.	Greider CW and Blackburn EH: The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell. 51:887–898. 1987. View Article : Google Scholar : PubMed/NCBI
11.	Bryan TM and Reddel RR: Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer. 33:767–773. 1997. View Article : Google Scholar : PubMed/NCBI
12.	Broccoli D, Young JW and de Lange T: Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA. 92:9082–9086. 1995. View Article : Google Scholar : PubMed/NCBI
13.	Ryan KM and Birnie GD: Cell-cycle progression is not essential for c-Myc to block differentiation. Oncogene. 14:2835–2843. 1997. View Article : Google Scholar : PubMed/NCBI
14.	Wu KJ, Grandori C, Amacker M, et al: Direct activation of TERT transcription by c-MYC. Nat Genet. 21:220–224. 1999. View Article : Google Scholar : PubMed/NCBI
15.	Greider CW and Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 43:405–413. 1985. View Article : Google Scholar : PubMed/NCBI
16.	Mason M, Schuller A and Skordalakes E: Telomerase structure function. Curr Opin Struct Biol. 21:92–100. 2011. View Article : Google Scholar : PubMed/NCBI
17.	Feng J, Funk WD, Wang SS, et al: The RNA component of human telomerase. Science. 269:1236–1241. 1995. View Article : Google Scholar : PubMed/NCBI
18.	Morin GB: The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 59:521–529. 1989. View Article : Google Scholar : PubMed/NCBI
19.	Ly H: Genetic and environmental factors influencing human diseases with telomere dysfunction. Int J Clin Exp Med. 2:114–130. 2009.PubMed/NCBI
20.	Fu D and Collins K: Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol Cell. 28:773–785. 2007. View Article : Google Scholar : PubMed/NCBI
21.	Venteicher AS, Meng Z, Mason PJ, Veenstra TD and Artandi SE: Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell. 132:945–957. 2008. View Article : Google Scholar : PubMed/NCBI
22.	Zhong F, Savage SA, Shkreli M, et al: Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev. 25:11–16. 2011. View Article : Google Scholar : PubMed/NCBI
23.	Kelleher C, Teixeira MT, Forstemann K and Lingner J: Telomerase: biochemical considerations for enzyme and substrate. Trends Biochem Sci. 27:572–579. 2002. View Article : Google Scholar : PubMed/NCBI
24.	De Boeck G, Forsyth RG, Praet M and Hogendoorn PC: Telomere-associated proteins: cross-talk between telomere maintenance and telomere-lengthening mechanisms. J Pathol. 217:327–344. 2009.PubMed/NCBI
25.	Forsyth NR, Wright WE and Shay JW: Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation. 69:188–197. 2002. View Article : Google Scholar : PubMed/NCBI
26.	Kilian A, Bowtell DD, Abud HE, et al: Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet. 6:2011–2019. 1997. View Article : Google Scholar : PubMed/NCBI
27.	Ulaner GA, Hu JF, Vu TH, Giudice LC and Hoffman AR: Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 58:4168–4172. 1998.
28.	Ulaner GA, Hu JF, Vu TH, Oruganti H, Giudice LC and Hoffman AR: Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int J Cancer. 85:330–335. 2000. View Article : Google Scholar : PubMed/NCBI
29.	Cong YS, Wright WE and Shay JW: Human telomerase and its regulation. Microbiol Mol Biol Rev. 66:407–425. 2002. View Article : Google Scholar : PubMed/NCBI
30.	Sawyers CL, McLaughlin J, Goga A, Havlik M and Witte O: The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell. 77:121–131. 1994. View Article : Google Scholar : PubMed/NCBI
31.	Kharbanda S, Kumar V, Dhar S, et al: Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase. Curr Biol. 10:568–575. 2000. View Article : Google Scholar : PubMed/NCBI
32.	Tomlinson RL, Ziegler TD, Supakorndej T, Terns RM and Terns MP: Cell cycle-regulated trafficking of human telomerase to telomeres. Mol Biol Cell. 17:955–965. 2006. View Article : Google Scholar : PubMed/NCBI
33.	Jady BE, Richard P, Bertrand E and Kiss T: Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres. Mol Biol Cell. 17:944–954. 2006. View Article : Google Scholar : PubMed/NCBI
34.	Cioce M and Lamond AI: Cajal bodies: a long history of discovery. Annu Rev Cell Dev Biol. 21:105–131. 2005. View Article : Google Scholar : PubMed/NCBI
35.	Wojtyla A, Gladych M and Rubis B: Human telomerase activity regulation. Mol Biol Rep. 38:3339–3349. 2011. View Article : Google Scholar
36.	Jady BE, Bertrand E and Kiss T: Human telomerase RNA and box H/ACA scaRNAs share a common Cajal body-specific localization signal. J Cell Biol. 164:647–652. 2004. View Article : Google Scholar : PubMed/NCBI
37.	Lukowiak AA, Narayanan A, Li ZH, Terns RM and Terns MP: The snoRNA domain of vertebrate telomerase RNA functions to localize the RNA within the nucleus. RNA. 7:1833–1844. 2001.PubMed/NCBI
38.	Etheridge KT, Banik SS, Armbruster BN, et al: The nucleolar localization domain of the catalytic subunit of human telomerase. J Biol Chem. 277:24764–24770. 2002. View Article : Google Scholar : PubMed/NCBI
39.	Yang Y, Chen Y, Zhang C, Huang H and Weissman SM: Nucleolar localization of hTERT protein is associated with telomerase function. Exp Cell Res. 277:201–209. 2002. View Article : Google Scholar : PubMed/NCBI
40.	Aisner DL, Wright WE and Shay JW: Telomerase regulation: not just flipping the switch. Curr Opin Genet Dev. 12:80–85. 2002. View Article : Google Scholar : PubMed/NCBI
41.	Collins K: Physiological assembly and activity of human telomerase complexes. Mech Ageing Dev. 129:91–98. 2008. View Article : Google Scholar : PubMed/NCBI
42.	McEachern MJ, Krauskopf A and Blackburn EH: Telomeres and their control. Annu Rev Genet. 34:331–358. 2000. View Article : Google Scholar
43.	Taggart AK, Teng SC and Zakian VA: Est1p as a cell cycle-regulated activator of telomere-bound telomerase. Science. 297:1023–1026. 2002. View Article : Google Scholar : PubMed/NCBI
44.	Bachand F, Boisvert FM, Cote J, Richard S and Autexier C: The product of the survival of motor neuron (SMN) gene is a human telomerase-associated protein. Mol Biol Cell. 13:3192–3202. 2002. View Article : Google Scholar : PubMed/NCBI
45.	Tomlinson RL, Abreu EB, Ziegler T, et al: Telomerase reverse transcriptase is required for the localization of telomerase RNA to cajal bodies and telomeres in human cancer cells. Mol Biol Cell. 19:3793–3800. 2008. View Article : Google Scholar : PubMed/NCBI
46.	Li H: Unveiling substrate RNA binding to H/ACA RNPs: one side fits all. Curr Opin Struct Biol. 18:78–85. 2008. View Article : Google Scholar : PubMed/NCBI
47.	Venteicher AS, Abreu EB, Meng Z, et al: A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science. 323:644–648. 2009. View Article : Google Scholar : PubMed/NCBI
48.	Cheng X and Roberts RJ: AdoMet-dependent methylation, DNA methyltransferases and base flipping. Nucleic Acids Res. 29:3784–3795. 2001. View Article : Google Scholar : PubMed/NCBI
49.	Hamma T, Reichow SL, Varani G and Ferre-D’Amare AR: The Cbf5-Nop10 complex is a molecular bracket that organizes box H/ACA RNPs. Nat Struct Mol Biol. 12:1101–1107. 2005. View Article : Google Scholar : PubMed/NCBI
50.	Pogacic V, Dragon F and Filipowicz W: Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol Cell Biol. 20:9028–9040. 2000. View Article : Google Scholar : PubMed/NCBI
51.	Maiorano D, Brimage LJ, Leroy D and Kearsey SE: Functional conservation and cell cycle localization of the Nhp2 core component of H + ACA snoRNPs in fission and budding yeasts. Exp Cell Res. 252:165–174. 1999.PubMed/NCBI
52.	Girard JP, Caizergues-Ferrer M and Lapeyre B: The SpGAR1 gene of Schizosaccharomyces pombe encodes the functional homologue of the snoRNP protein GAR1 of Saccharomyces cerevisiae. Nucleic Acids Res. 21:2149–2155. 1993. View Article : Google Scholar : PubMed/NCBI
53.	Cossu F, Vulliamy TJ, Marrone A, Badiali M, Cao A and Dokal I: A novel DKC1 mutation, severe combined immunodeficiency (T+B-NK- SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome. Br J Haematol. 119:765–768. 2002.PubMed/NCBI
54.	Wong JM, Kyasa MJ, Hutchins L and Collins K: Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita. Hum Genet. 115:448–455. 2004.PubMed/NCBI
55.	Vulliamy T, Beswick R, Kirwan M, et al: Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci USA. 105:8073–8078. 2008. View Article : Google Scholar : PubMed/NCBI
56.	Walne AJ, Vulliamy T, Marrone A, et al: Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet. 16:1619–1629. 2007. View Article : Google Scholar : PubMed/NCBI
57.	Heiss NS, Knight SW, Vulliamy TJ, et al: X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet. 19:32–38. 1998. View Article : Google Scholar : PubMed/NCBI
58.	Meier UT: The many facets of H/ACA ribonucleoproteins. Chromosoma. 114:1–14. 2005. View Article : Google Scholar : PubMed/NCBI
59.	Parry EM, Alder JK, Lee SS, et al: Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita. J Med Genet. 48:327–333. 2011. View Article : Google Scholar : PubMed/NCBI
60.	Tomlinson RL, Li J, Culp BR, Terns RM and Terns MP: A Cajal body-independent pathway for telomerase trafficking in mice. Exp Cell Res. 316:2797–2809. 2010. View Article : Google Scholar : PubMed/NCBI
61.	Lin J, Jin R, Zhang B, et al: Nucleolar localization of TERT is unrelated to telomerase function in human cells. J Cell Sci. 121:2169–2176. 2008. View Article : Google Scholar : PubMed/NCBI
62.	Wong JM, Kusdra L and Collins K: Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat Cell Biol. 4:731–736. 2002. View Article : Google Scholar : PubMed/NCBI
63.	Gallardo F and Chartrand P: Telomerase biogenesis: The long road before getting to the end. RNA Biol. 5:212–215. 2008. View Article : Google Scholar : PubMed/NCBI
64.	Collins K: The biogenesis and regulation of telomerase holoenzymes. Nat Rev Mol Cell Biol. 7:484–494. 2006. View Article : Google Scholar : PubMed/NCBI
65.	Grozdanov PN, Roy S, Kittur N and Meier UT: SHQ1 is required prior to NAF1 for assembly of H/ACA small nucleolar and telomerase RNPs. RNA. 15:1188–1197. 2009. View Article : Google Scholar : PubMed/NCBI
66.	Abreu E, Aritonovska E, Reichenbach P, et al: TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo. Mol Cell Biol. 30:2971–2982. 2010. View Article : Google Scholar : PubMed/NCBI
67.	Cifuentes-Rojas C and Shippen DE: Telomerase regulation. Mutat Res. 730:20–27. 2012. View Article : Google Scholar : PubMed/NCBI
68.	Collins K and Mitchell JR: Telomerase in the human organism. Oncogene. 21:564–579. 2002. View Article : Google Scholar : PubMed/NCBI
69.	Venteicher AS and Artandi SE: TCAB1: driving telomerase to Cajal bodies. Cell Cycle. 8:1329–1331. 2009. View Article : Google Scholar : PubMed/NCBI
70.	Wang F, Podell ER, Zaug AJ, et al: The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature. 445:506–510. 2007. View Article : Google Scholar : PubMed/NCBI
71.	Xin H, Liu D, Wan M, et al: TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature. 445:559–562. 2007. View Article : Google Scholar : PubMed/NCBI
72.	Shore D and Bianchi A: Telomere length regulation: coupling DNA end processing to feedback regulation of telomerase. EMBO J. 28:2309–2322. 2009. View Article : Google Scholar : PubMed/NCBI
73.	Smogorzewska A, van Steensel B, Bianchi A, et al: Control of human telomere length by TRF1 and TRF2. Mol Cell Biol. 20:1659–1668. 2000. View Article : Google Scholar : PubMed/NCBI
74.	Ancelin K, Brunori M, Bauwens S, et al: Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol Cell Biol. 22:3474–3487. 2002. View Article : Google Scholar : PubMed/NCBI
75.	Roth A, Harley CB and Baerlocher GM: Imetelstat (GRN163L)--telomerase-based cancer therapy. Recent Results Cancer Res. 184:221–234. 2010. View Article : Google Scholar : PubMed/NCBI
76.	Chakraborty S, Ghosh U, Bhattacharyya NP, Bhattacharya RK and Roy M: Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells. Mutat Res. 596:81–90. 2006. View Article : Google Scholar : PubMed/NCBI
77.	Mukherjee Nee Chakraborty S, Ghosh U, Bhattacharyya NP, Bhattacharya RK, Dey S and Roy M: Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity. Mol Cell Biochem. 297:31–39. 2007.PubMed/NCBI
78.	Ramachandran C, Fonseca HB, Jhabvala P, Escalon EA and Melnick SJ: Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line. Cancer Lett. 184:1–6. 2002. View Article : Google Scholar : PubMed/NCBI
79.	Lee JH and Chung IK: Curcumin inhibits nuclear localization of telomerase by dissociating the Hsp90 co-chaperone p23 from hTERT. Cancer Lett. 290:76–86. 2010. View Article : Google Scholar : PubMed/NCBI
80.	Moon DO, Kang SH, Kim KC, Kim MO, Choi YH and Kim GY: Sulforaphane decreases viability and telomerase activity in hepatocellular carcinoma Hep3B cells through the reactive oxygen species-dependent pathway. Cancer Lett. 295:260–266. 2010. View Article : Google Scholar